<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-14T07:53:05Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:11351/12569" metadataPrefix="oai_dc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:11351/12569</identifier><datestamp>2025-10-24T10:17:29Z</datestamp><setSpec>com_2072_378070</setSpec><setSpec>com_2072_378040</setSpec><setSpec>col_2072_378092</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>The effectiveness of mapping-targeted biopsies on the index lesion in transperineal prostate biopsies</dc:title>
   <dc:creator>Tcholakian, Larisa</dc:creator>
   <dc:creator>Alomar, Xavier</dc:creator>
   <dc:creator>Barranco, Miguel</dc:creator>
   <dc:creator>Paesano, Nahuel</dc:creator>
   <dc:creator>Catalá, Violeta</dc:creator>
   <dc:creator>Enrique, Trilla Herrera</dc:creator>
   <dc:creator>Morote Robles, Juan</dc:creator>
   <dc:contributor>Institut Català de la Salut</dc:contributor>
   <dc:contributor>[Paesano N, Catalá V, Tcholakian L, Alomar X, Barranco M] Creu Blanca Clinic Barcelona, Catalunya, Spain.  [Trilla E, Morote J] Servei d’Urologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Department of Surgery, Universitat Autònoma de Barcelona, Bellaterra, Spain</dc:contributor>
   <dc:contributor>Vall d'Hebron Barcelona Hospital Campus</dc:contributor>
   <dc:subject>Pròstata - Càncer - Imatgeria</dc:subject>
   <dc:subject>Pròstata - Biòpsia</dc:subject>
   <dc:subject>DISEASES::Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Genital Neoplasms, Male::Prostatic Neoplasms</dc:subject>
   <dc:subject>Other subheadings::Other subheadings::Other subheadings::/diagnostic imaging</dc:subject>
   <dc:subject>ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Diagnostic Techniques and Procedures::Clinical Laboratory Techniques::Cytological Techniques::Cytodiagnosis::Biopsy::Image-Guided Biopsy</dc:subject>
   <dc:subject>ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias de los genitales masculinos::neoplasias de la próstata</dc:subject>
   <dc:subject>Otros calificadores::Otros calificadores::Otros calificadores::/diagnóstico por imagen</dc:subject>
   <dc:subject>TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::técnicas y procedimientos diagnósticos::técnicas de laboratorio clínico::técnicas citológicas::citodiagnóstico::biopsia::biopsia guiada por imágenes</dc:subject>
   <dc:description>Prostate; Prostatic Neoplasm; Retrospective Studies</dc:description>
   <dc:description>Próstata; Neoplasia de la próstata; Estudios retrospectivos</dc:description>
   <dc:description>Pròstata; Neoplàsia de la pròstata; Estudis retrospectius</dc:description>
   <dc:description>Purpose: To evaluate the effectiveness of mapping-targeted biopsies (MTB) on the index lesion for the detection of clinically significant prostate cancer (csPCa) in transperineal fusion-image prostate biopsies.&#xd;
Materials and methods: A retrospective analysis was conducted on 309 men with suspected PCa who underwent prostate biopsies at the Creu Blanca reference center in Barcelona, Spain. The Prostate Imaging-Reporting and Data System (PI-RADS v.2.1) of the magnetic resonance images (MRI) were reclassified by an expert radiologist reading of pre-biopsy biparametric MRI used for segmentation of suspected lesions. Transperineal MTB of suspicious lesions and 12-core systematic biopsies were performed using the Artemis™ platform. CsPCa was defined as International Society of Urological Pathology grade group ≥ 2.&#xd;
Results: CsPCa was detected in 192 men (62.1%), with detection rates of 6.3% for PI-RADS 2, 26.8% for PI-RADS 3, 87.3% for PI-RADS 4, and 93.1% for PI-RADS 5. MTB of the index lesion identified 185 csPCa (96.3%). CsPCa was detected solely in systematic biopsies in three cases (1.6%), while an additional four cases (2.1%) were identified only in the second suspected lesion. A predictive model for csPCa detection in MTB of the index lesion was developed, with an AUC of 0.918 (95% CI 0.887-0.950).&#xd;
Conclusions: This model had the potential to avoid 23.3% of prostate biopsies without missing additional csPCa cases. MTB of the index lesion was highly effective for identifying csPCa in fusion transperineal prostate biopsies. A developed predictive model successfully reduced the need for almost one quarter of biopsies without missing csPCa cases.</dc:description>
   <dc:date>2025-02-10T06:53:08Z</dc:date>
   <dc:date>2025-02-10T06:53:08Z</dc:date>
   <dc:date>2024-05</dc:date>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
   <dc:identifier>Paesano N, Catalá V, Tcholakian L, Alomar X, Barranco M, Trilla E, et al. The effectiveness of mapping-targeted biopsies on the index lesion in transperineal prostate biopsies. Int Braz J Urol. 2024 May;50(3):296–308.</dc:identifier>
   <dc:identifier>1677-6119</dc:identifier>
   <dc:identifier>https://hdl.handle.net/11351/12569</dc:identifier>
   <dc:identifier>10.1590/S1677-5538.IBJU.2023.0558</dc:identifier>
   <dc:identifier>38446907</dc:identifier>
   <dc:identifier>001202820000015</dc:identifier>
   <dc:identifier>http://hdl.handle.net/11351/12569</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>International Braz J Urol;50(3)</dc:relation>
   <dc:relation>https://doi.org/10.1590/S1677-5538.IBJU.2023.0558</dc:relation>
   <dc:rights>Attribution 4.0 International</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>Sociedade Brasileira de Urologia</dc:publisher>
   <dc:source>Scientia</dc:source>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>